Evidence map›Paper›PMID 18383036›Full record

ArticleEuropean journal of immunology2008

Proliferation and interleukin 5 production by CD8hi CD57+ T cells.

Lee K Chong, Rebecca J Aicheler, Sian Llewellyn-Lacey, Peter Tomasec, Paul Brennan, Eddie C Y Wang

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Reliable Hallmarks and Biomarkers of Senescent Lymphocytes.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Is There a Positive Side to T Cell Exhaustion?Frontiers in immunology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Immune and myodegenerative pathomechanisms in inclusion body myositis.Annals of clinical and translational neurology · 2017
    Review
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lee K ChongDepartment of Medical Biochemistry & Immunology, School of Medicine, Cardiff University, Cardiff, UK.
Rebecca J Aicheler
Sian Llewellyn-Lacey
Peter Tomasec
Paul Brennan
Eddie C Y Wang
Cardiff University · GB

Funding

Medical Research Council g0300180Medical Research Council G0300180Medical Research Council G0300180(65735)Medical Research Council g0500617Medical Research Council G0500617Medical Research Council G0500617(74644)Wellcome Trust 066749Wellcome Trust gr066749
6 · The paper itself

Abstract

CD8hi CD57+ T cells have previously been described as effector memory T cells with minimal expansion capacity and high susceptibility to activation-induced cell death. In contrast, we demonstrate here that CD8hi CD57+ T cells are capable of rapid expansion using multiple techniques including [(3)H]thymidine uptake, flow cytometric bead-based enumeration and standard haemocytometer counting. Previous reports can be explained by marked inhibition of activation-induced expansion and increased 7-amino-actinomycin D uptake by CD8hi CD57+ T cells following treatment with CFSE, a dye previously used to measure their proliferation, combined with specific media requirements for the growth of this cell subset. The ability of CD8hi CD57+ T cells to further differentiate is highlighted by a distinct cytokine profile late after activation that includes the unexpected release of high levels of interleukin 5. These data indicate that CD8hi CD57+ T cells should not be considered as "end-stage" effector T cells incapable of proliferation, but represent a highly differentiated subset capable of rapid division and exhibiting novel functions separate from their previously described cytotoxic and IFN-gamma responses.

Indexed as

AdultCD57 AntigensCD8 AntigensCD8-Positive T-LymphocytesCell ProliferationCells, CulturedDactinomycinFluoresceinsHumansInterleukin-5Middle AgedSuccinimides5-(6)-carboxyfluorescein diacetate succinimidyl ester7-aminoactinomycin DCD57 AntigensCD8 AntigensDactinomycinFluoresceinsInterleukin-5Succinimides

Identifiers

PMID18383036
PMCPMC2843081
OpenAlexW1992675017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.